Esmolol Infusion in Patients Undergoing Craniotomy
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
Anesthesia techniques that minimize anesthetic requirements and their effects may be
beneficial. Esmolol, a short acting hyperselective β-adrenergic blocker is effective in
blunting adrenergic response to several perioperative stimuli and so it might interfere in
the effect of the anesthetic drugs on the brain. This study was designed to investigate the
effect of esmolol on the consumption of propofol and sevoflurane in patients undergoing
craniotomy.